G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.

Qiao HF, Liu YL, You J, Zheng YL, Chen LP, Lu XY, Du L, Shan F, Liu MH

Open source

DOI
10.1016/j.jri.2020.103129
Published
2020 Aug
Container
Journal of reproductive immunology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jri.2020.103129,
  title = {G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.},
  author = {Qiao HF and Liu YL and You J and Zheng YL and Chen LP and Lu XY and Du L and Shan F and Liu MH},
  year = {2020},
  journal = {Journal of reproductive immunology},
  doi = {10.1016/j.jri.2020.103129},
  url = {https://doi.org/10.1016/j.jri.2020.103129}
}

RIS

TY  - JOUR
TI  - G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.
AU  - Qiao HF
AU  - Liu YL
AU  - You J
AU  - Zheng YL
AU  - Chen LP
AU  - Lu XY
AU  - Du L
AU  - Shan F
AU  - Liu MH
PY  - 2020
JO  - Journal of reproductive immunology
DO  - 10.1016/j.jri.2020.103129
UR  - https://doi.org/10.1016/j.jri.2020.103129
ER  - 

APA

HF, Q., YL, L., J, Y., YL, Z., LP, C., XY, L., L, D., F, S., & MH, L. (2020). G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.. Journal of reproductive immunology. https://doi.org/10.1016/j.jri.2020.103129

Source records